Notify me when Lin Bioscience International Ltd. files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| BLTE | Belite Bio, Inc | Ordinary shares, par value US$0.0001 per share | 53.7% | $1.07B | 17.1M | Lin Bioscience International Ltd. | 31 Dec 2024 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|